Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
FDA/EMA/Drug Designation
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…
FDA/EMA/Drug Designation
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…
Commercial
BioSpace Movers & Shakers, Oct. 30
Commercial
Q32 Stays Busy with $60 Million Series B and First Dose…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
FDA/EMA/Drug Designation
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…
Commercial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…
FDA/EMA/Drug Designation
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
FDA/EMA/Drug Designation
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…
Home
Clinical
FDA/EMA/Drug Designation
FDA/EMA/Drug Designation
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
FDA/EMA/Drug Designation
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020
Biospace News
-
November 5, 2020
FDA/EMA/Drug Designation
BCG Vaccination at Birth Reduces Incidence of Non-Tuberculosis Infections in Newborns: Presented at ESPID – FirstWord Pharma
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
October 31, 2020
0
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
October 31, 2020
0
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
October 31, 2020
0
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
October 31, 2020
0
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
October 31, 2020
0
1
2
3
...
117
Page 1 of 117
- Advertisement -
MOST POPULAR
Navidea Biopharmaceuticals Announces $4.2 Million Sale of Ohio Court Judgment and...
February 14, 2020
March Pharma Conferences to Proceed as Planned Despite COVID-19 Concerns
March 4, 2020
Five Prime Asset Paired with Opdivo Flunks Mid-Stage Pancreatic Cancer Trial
February 19, 2020
Andexxa Highlighted as a First-Line Factor Xa Reversal Option by the...
November 15, 2019
Load more
HOT NEWS
FDA/EMA/Drug Designation
Rockwell Medical, Inc. Receives FDA Approval for Triferic AVNU (Ferric Pyrophosphate...
FDA/EMA/Drug Designation
Rockwell Medical, Inc. Announces $35 Million Debt Financing Agreement with Innovatus...
Acquisitions
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
Commercial
Inventiva announces temporary trading halt of its ordinary shares on Euronext...
